Sugi Predict

Sugi Predict / Targets / LTN1

LTN1

E3 ubiquitin-protein ligase listerin · O94822 · LTN1 on Sugi Atlas →

0 patent compounds predicted against LTN1, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to LTN1 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Montelukast for Early Life Wheezing PHASE2/PHASE3COMPLETED
Testosterone and Long Pulse Stimulation After SCI PHASE2COMPLETED
Clinical Study of EBV-LMP1 Targeted DNAzyme to Treat Nasopharyngeal Carcinoma PHASE1/PHASE2COMPLETED
Safety Study of a Gene Transfer Vector (Rh.10) for Children With Late Infantile Neuronal Ceroid Lipofuscinosis (LINCL) PHASE1COMPLETED
PS-341 and Radiation to Treat Advanced Cancer of the Head and Neck PHASE1COMPLETED
Nilotinib in Huntington's Disease PHASE1UNKNOWN
Human Leukocyte Antigen (HLA) - A*2402 Restricted Peptide Vaccine Therapy in Patients With Advanced Esophageal Cancer PHASE1COMPLETED
The Treatment of Advanced Lung Cancer With Dribbles Antigen by Targeting Activation of Tcells PHASE1UNKNOWN
Endometriosis and Microvascular Dysfunction: Role of Inflammation EARLY_PHASE1RECRUITING
Biomarker of Children With Familial Autoimmune History nanCOMPLETED
Clinical Study of 68Ga-DOTA-BLP PET Imaging in Noninvasive Diagnosis of Malignant Tumors nanNOT_YET_RECRUITING
Study of Proteins in Head and Neck Cancer Cells nanCOMPLETED
Establishment of a Prospective Clinical-biological Database nanRECRUITING
Exploring Novel Biomarkers of ICU-AW in Mechanically Ventilated Children at the Molecular Level nanENROLLING_BY_INVITATION
Immune Cell Response to Stimuli nanRECRUITING
Safety and Tolerability of a Nutritional Formula Designed to Aid in Maintenance of Muscle During Periods of Caloric Restriction in Adults nanNOT_YET_RECRUITING
Amyotrophic Lateral Sclerosis (ALS) Families Project nanRECRUITING
The Development of Human Papillomavirus Type 16 E7-Specific Human Immunologic Assays in Non-HLA2 Type Human Being nanUNKNOWN
Amyotrophic Lateral Sclerosis (ALS) Tissue Donation Program nanCOMPLETED
Exercise Therapy to Reduce Heart Failure Symptoms; Sorting Mechanisms of Benefit nanCOMPLETED
Comparison of the Human Papillomavirus (HPV) Type 16 E7-Specific Immune Response Between a Normal Population and Patients With Cervical Lesions nanUNKNOWN
TL1A Expression in Psoriatic Skin nanUNKNOWN
Genetics of Familial and Sporadic ALS nanCOMPLETED
Genetic Variation in TRAF3IP2 (rs13190932) nanRECRUITING
Molecular Mechanisms of Fibrillin/LTBP Superfamily in Renal Fibrosis and Cardiorenal Syndrome nanUNKNOWN
Identification of a New Gene Involved in Hereditary Lipodystrophy nanCOMPLETED
LRP1 and Colon Cancer nanUNKNOWN
Genetic Susceptibility and Biomarkers in Listeriosis nanCOMPLETED
The PREServation of MUScle Function in Critically Ill Patients (PRESMUS) nanUNKNOWN
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a LTN1 binder may also engage these)

ProteinNameSimilarity
E1C231 — 1.000 E1C231 →
P97313 — 1.000 P97313 →
Q6A009 — 1.000 Q6A009 →
SMG1 Serine/threonine-protein kinase SMG1 0.997 landscape →
Q8H0T4 — 0.995 Q8H0T4 →
Q9C0Z4 — 0.995 Q9C0Z4 →
TEX10 Testis-expressed protein 10 0.995 landscape →
Q8WN22 — 0.995 Q8WN22 →
O74447 — 0.995 O74447 →
E1C2Z0 — 0.994 E1C2Z0 →
Q6PQD5 — 0.994 Q6PQD5 →
Q8BJW5 — 0.994 Q8BJW5 →
Q9SXA1 — 0.994 Q9SXA1 →
O74349 — 0.994 O74349 →
Q8QGX4 — 0.994 Q8QGX4 →
B1AUR6 — 0.993 B1AUR6 →
Q9DE14 — 0.993 Q9DE14 →
UTP20 Small subunit processome component 20 homolog 0.993 landscape →
Q9FIN7 — 0.993 Q9FIN7 →
RIF1 Telomere-associated protein RIF1 0.993 landscape →
E1BGH8 — 0.993 E1BGH8 →
Q6ZQK0 — 0.992 Q6ZQK0 →
Q3MHH2 — 0.992 Q3MHH2 →
Q640K1 — 0.992 Q640K1 →
Q8TDB6 — 0.992 Q8TDB6 →
Q8BKX6 — 0.992 Q8BKX6 →
P0DJD0 — 0.992 P0DJD0 →
Q9DEI1 — 0.991 Q9DEI1 →
Q9BVR0 — 0.991 Q9BVR0 →
Q9VW09 — 0.991 Q9VW09 →